Navigation Links
NeoVista, Inc. Announces the Launch of VIDION ANV Therapy System in UK for Treating Wet Age-Related Macular Degeneration
Date:11/16/2009

King’s College Hospital, London, Performs First Pioneering Surgical Procedure.

Fremont, CA and London, UK (PRWEB) November 16, 2009 -- NeoVista, Inc. announced today that the company’s revolutionary new surgical device is now available in the UK and offers fresh hope to 250,000 patients with wet age-related macular degeneration (AMD) –- a debilitating and aggressive eye condition that can lead to blindness within 3 months if left untreated. Every year 26,000 new cases of wet AMD are diagnosed in the UK.

The VIDION® Anti NeoVascular (ANV®) Therapy System, developed by NeoVista Inc and distributed by Carleton Ltd in the UK, has recently received a CE mark certifying that it has met the EU’s Medical Device Directive.

The new device is initially being introduced in 15 hospitals across the UK as part of a large clinical trial called MERLOT, where it will be used in patients whose current standard of care treatment involves regular injections of a drug into the eye to control their condition (up to one injection every month, indefinitely). Although the treatment is initially only available at select hospitals, it is anticipated that the number of sites using the device will increase quickly, to provide nationwide availability.

The MERLOT trial has been recently awarded portfolio status by The National Institute for Health Research (NIHR) Comprehensive Clinical Research Network (CCRN). The CCRN was created as part of the government’s research and development strategy, “Best Research for Best Health” to provide a world-class infrastructure for clinical trials in all areas of disease and clinical need within the NHS in UK.

Mr Tim Jackson, a Consultant Eye Surgeon at King’s College Hospital, who is the lead investigator for MERLOT said: “This is a relatively straightforward operation and the published results are
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. NeoVista, Inc. Announces First Neovascular AMD Patient Treated with VIDION ANV Therapy System in Europe Following Commercialization
2. NeoVista, Inc. Announces Initial VIDION Shipments
3. Dishler Laser Institute Announces Dr. Jon Dishler Selected as a Leading Laser Eye Surgeon of the United States, as Seen in Forbes Magazine
4. Ross Daniel Adaptive Apparel Announces Company Debut and 'Cool Clothes for Toes'
5. Dishler Laser Institute Announces Dr. Jon Dishler Selected as a Leading Laser Eye Surgeon of the United States, as Seen in Forbes Magazine
6. Concuity Announces Next-Generation Revenue Cycle Management Solution
7. Nutra Pharma Announces Plans to Begin Drug Registration Process in South America for its Over-the-Counter Pain Reliever
8. Westaim announces 2009 third quarter results
9. Human Pheromone Sciences Announces Third Quarter Results
10. Tender Corp. Announces Participation at Silicon Valley Moms Group's Holiday Coupon Guide & Party
11. Echo Therapeutics Announces $3 Million Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... Age, gender, genetics affect odds of remaining recurrence-free, research ... U.S. scientists have discovered there are genetic profiles that ... cancers, and those profiles differ depending on the age ... genetic and clinical data from 787 patients who were ... or above age 70). The findings are published in ...
(Date:2/9/2010)... folic acid, high blood pressure restrict fetal growth, study ... lifestyle habits you bring into pregnancy can have lasting ... A Dutch study found that women who smoked, had ... early pregnancy had babies that were smaller in the ... of complications later. , "Our study demonstrates that several ...
(Date:2/9/2010)... The following statement is ... M.D., President, American Medical Association: ,, (Logo: ... Medical Association is pleased to support First ... Let,s Move Campaign. As the nation,s largest ... address obesity and are committed to reenergizing ...
(Date:2/9/2010)... in captivity primarily for their skins, but some restaurants ... A study shows that eating these animals can have ... eating this ,delicacy., , Parasites, bacteria and viruses, and ... residues of veterinary drugs- eating reptile meat can cause ... a study published in the International Journal of ...
(Date:2/9/2010)... Dr. Franois Robert, a researcher at the Institut de ... team of Dr. Daniel Durocher (Samuel Lunenfeld Research Institute ... mapped all the fragile sites of a living organism, ... used by the researchers can be applied to humans. ... scientific journal Nature Structural and Molecular Biology . ...
Breaking Medicine News(10 mins):Health News:Genes Play Role in Prognosis With Non-Small Cell Lung Cancers 2Health News:Mom's Lifestyle in Early Pregnancy Affects Baby's Size 2Health News:Mom's Lifestyle in Early Pregnancy Affects Baby's Size 3Health News:Study carried out into biological risks of eating reptiles 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 2Health News:Researchers map all the fragile sites of the yeast Saccharomyces cerevisiae's genome 3
... study neurosurgeons say they are now convinced that helmets ... the past have suggested wearing helmets during a motorcycle ... of skull base and cervical-spine (or neck) injuries secondary ... researchers to study whether helmets harm or hurt adolescent ...
... women with leukemia who died after receiving a bone marrow ... shows evidence of the transplanted // cells up to six ... marrow cells were actually acting as stem cells -- basic ... the body, and once thought to be found only in ...
... by adding more calcium to the diet may help reduce ... ,In a study of more than 95,000 women who never ... the eight years of the study. Women who consumed the ... stones compared to women who consumed the least amount. The ...
... United States. Investigators have been tracking the health of men and ... factors might impact their risk for heart disease and stroke. In ... and without a history of stroke.About 20 percent of the people ... of those who didn’t have a stroke. ,A good way ...
... suffer a stroke. About one-third of those strokes are recurrent. ... that consume lots of energy, such as dressing, bathing, walking ... survivors should be urged to exercise more at least 20 ... can help reduce the risk of another stroke. Strength training, ...
... a human papillomavirus ( HPV ) vaccination with cervical cancer ... all cervical cancers. According to a recent study it was ... caused by HPV, and 9 percent are preceded by persistent ... detect cervical cancer but it is not available to all ...
Other Medicine News:
(Date:2/9/2010)... Feb. 9 Palatin Technologies, ... the completion of first cohort dosing in a ... treatment for sexual dysfunction.  The primary endpoint in ... pressure effects of subcutaneous bremelanotide in men between ... also evaluate consistency of plasma exposure of bremelanotide ...
(Date:2/9/2010)... LAUSANNE , Switzerland , February ... Swiss-based global biopharmaceutical group of companies with,a ... that target unmet medical,needs, today announced the ... for the development, manufacture and commercialisation of ... inhibitor with a,potent anti-hepatitis C virus (HCV) ...
(Date:2/8/2010)... Calif. , Feb. 8 PreXion, ... quality 3D Cone Beam Imaging systems for dentistry, today ... as Director of Marketing. ,, PreXion President/COO ... Keith on our senior management team and I look ... extensive sales and marketing leadership, experience and success in ...
Breaking Medicine Technology:Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 2Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 3Palatin Technologies, Inc. Announces Dosing of Subcutaneous Bremelanotide Trial in Men 4Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 2Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 3PreXion, Inc. Announces Appointment of Director of Marketing 2Icahn Indicates That Biogen Board Refuses To Close Polls 12450 1MDCT angiography leads to successful treatment of severely blocked arteries in the legs 47804 1Biologists consider unifying framework to explain evolutionary puzzles 8709 1Biologists consider unifying framework to explain evolutionary puzzles 8709 2
... Inc. (OTC Bulletin Board: PLCSF), a company focused on ... that the first data from its pilot safety trial ... at the American College of Cardiology Annual Conference, on ... Florida. The poster will be presented by Dr. ...
... Abstracts Will Be Featured at Annual Kidney Care MeetingEL ... provider of kidney care services for those diagnosed with ... DaVita Clinical Research(R), today announced that company representatives will ... Spring Clinical Meetings scheduled for March 25-29, 2009 in ...
Other Medicine Technology:RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009 2RenalGuard(R) Pilot Safety Clinical Trial Data to be Presented at ACC 2009 3DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium 2DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium 3DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium 4DaVita Abstracts Accepted Into National Kidney Foundation's 2009 Spring Symposium 5
... precision, ergonomics, and value!, Comfortable ... soft non-slip, contoured handle , Finer ... plunger spring action , Completely autoclavable ... the need for recalibration , Easy-to-read ...
Pipetman F is a fixed-volume, air-displacement pipette. Thirteen robust models cover a large volume range from 2 L to 1000 L, with Gilsons legendary accuracy and precision....
... Eppendorf Reference Series 2000 Pipette is a ... a compact and robust design, and superior ... used to operate the measuring stroke and ... Product features:Eppendorf "pipette/tip" system ensures utmost accuracy ...
... The Eppendorf Reference Series 2000 Pipette is ... stroke, a compact and robust design, and ... is used to operate the measuring stroke ... tip. Product features:Eppendorf "pipette/tip" system ensures utmost ...
Medicine Products: